Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Choleste...(mical Co. Ltd. is the world's largest su...),Health

Date:9/25/2008

mical Co. Ltd., is the world's largest supplier of the cholesterol-management agent pantethine, a derivative of vitamin B5, which it markets under the brand name Pantesin(R). Daiichi Fine Chemical has a reputation of strict pharmaceutical GMP standards at the firm's vertically integrated operation in Japan which are applied to Pantesin(R). Kyowa Hakko Kogyo Co., Ltd., Japan acquired all shares of Daiichi Fine Chemical from Daiichi-Sankyo Co., Ltd. in 2007. As a wholly owned subsidiary in Kyowa's bio-chemical business, Daiichi Fine Chemical continues to supply vitamin B5 of highest quality standards. For more information visit http://www.daiichi-fcj.co.jp

About KGK Synergize, Inc.

Created in 1997 by three experienced nutritional scientists from University of Western Ontario to facilitate commercialization of research and development findings, KGK Synergize, Inc. provides contract research services to health nutrition, biotechnology and pharmaceutical industries. In addition to providing contract research services, KGK's Product Development Division brings new and innovative natural health products to the point where they are ready to be manufactured and marketed. For more information visit http://www.kgksynergize.com

'/>"/>

SOURCE Daiichi Fine Chemical Co., Ltd. of Japan Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Leading Healthcare System Decreases MRSA Infection Rate by 53 Percent - Offers Protocol & Educational Materials Free of Charge to Other Organizations
2. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
3. FDA Lifts Clinical Hold on Gentas Tesetaxel, a Leading Oral Taxane
4. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
5. Leading Immunologists Convene in Boston
6. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
7. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
8. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
11. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection